Abstract
Despite considerable evidence for the involvement of the purine nucleotides GTP* and ATP in exocytosis, there is currently no consensus about their exact role(s). With regard to GTP (the focus of this chapter), our recent studies (1) have suggested that there is at least a permissive role for GTP in insulin release. Normal rat pancreatic islets were pretreated overnight with each of four structurally-dissimilar inhibitors of a rate-limiting step in the cytosolic production of GTP (inosine monophosphate dehydrogenase; IMPDH). When islet concentrations of GTP were inhibited by more than about 80% (to levels down to less than 0.6–0.7 pmol/islet), insulin release subsequently stimulated by nutrients (glucose or α-ketoisocaproate) or by aphorbol ester was reduced 40–60%. In contrast, insulin secretion induced by direct depolarization of β-cells (by 50 m M K+) was refractory to inhibition. These results were attributed to a depletion of islet GTP stores, since repletion of GTP by coprovision of guanine (but not the normalization of both ATP and UTP content by the provision of adenine) reversed the inhibitory effects of the drugs both on GTP content and on insulin release. In subsequent studies, we observed that lesser degrees of inhibition of GTP, or, conversely, a stimulation of islet GTP content (by provision of guanine alone) to levels about 25% above basal, did not have any discernible negative or positive modulatory effects on secretion. These findings suggested that islet GTP content is normally saturating, and therefore mild to moderate changes in these levels do not alter secretion. Since the average islet content of GTP approximates 750–1000 μM, it appears that a reduction in total islet GTP levels to less than 150–200 μM (or, possibly, a comparable relative reduction of free GTP levels, which may be one-fifth to one-twentieth of total levels; ref. 2) is needed to vitiate the effects of GTP on secretion. Such drastic changes are not likely to be induced by physiologic agonists (and in fact were not induced by glucose, which had relatively modest effects on total islet GTP content); therefore, we defined the effects of GTP as “permissive.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Metz SA, Rabaglia ME, Pintar TJ: Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets. J Biol Chem 267:12, 517-12, 527, 1992.
Otero A de S: Transphosphorylation and G protein activation. Biochem Pharmacol 39:1399–1404, 1990.
Haun RS, Tsai S-C, Adamik R, Moss J, Vaughan M: Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi. J Biol Chem 268:7064–7068, 1993.
Lillie THW, Gomperts BD: Guanine nucleotide is essential and Ca2+ is a modulator in the exocytotic reaction of permeabilized rat mast cells. Biochem J 288:181–187, 1992.
Lillie THW, Gomperts BD: Kinetic characterization of guanine-nucleotide-induced exocytosis from permeabilized rat mast cells. Biochem J 290:389–394, 1993.
Ahnert-Hilger G, Dayanithi G, Spicher K, Nordmann JJ: G-proteins mediate inhibition and activation of Ca2+-induced exocytosis from SLO-permeabilized peptidergic nerve endings. Biosci Rep 12:463–469, 1992.
Metz SA, Meredith M, Kowluru A: Purine nucleotide metabolism and GTP-binding proteins in the pancreatic β-cell. In Frontiers of Pancreatic β-Cell Research (Flatt PR, ed.), 1994, in press.
Metz SA, Meredith M, Rabaglia ME, Kowluru A: Small elevations of glucose concentration re-direct and amplify the synthesis of GTP in rat islets. J Clin Invest 92:872–882, 1993.
Welsh N, Sandier S, Welsh M, Hellerströ M: Regulation of RNA metabolism in relation to insulin production and oxidative metabolism in mouse pancreatic islets in vitro. Biochim Biophys Acta 887:58–68, 1986.
Liang Y, Najafi H, Smith RM, Zimmerman EC, Magnuson MA, Tal M, Matschinsky FM: Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes 41:792–806, 1992.
Metz SA: Epinephrine impairs insulin release by a mechanism distal to calcium mobilization. Similarity to lipoxygenase inhibitors. Diabetes 37:65–73, 1988.
Gembal M, Detimary P, Gilon P, Gao Z-Y, Henquin J-C: Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest 91:871–880, 1993.
Ullrich, S, Prentki, M, Wollheim, CB: Somatostatin inhibition of Ca2+-induced insulin secretion in permeabilized HIT-T15 cells. Biochem J 270:273–276, 1990.
Koffer A: Calcuim-induced secretion from permeabilized rat mast cells: requirements for guanine nucleotides. Biochim Biophys Acta 1176:231–239, 1993.
Lauquin GJM, Villiers C, Michejda JW, Hryniewiecka LV, Vignais PV: Adenine nucleotide transport in sonic submitochondrial particles. Kinetic properties and binding of specific inhibitors. Biochim Biophys Acta 460:331–345, 1977.
MacDonald MJ, Fahien LA: Glyceraldehyde phosphate and methyl esters of succinic acid. Two “new” potent insulin secretagogues. Diabetes 37:997–999, 1988.
Fahien LA, MacDonald MJ, Kmiotek EH, Mertz RJ, Fahien CM: Regulation of insulin release by factors that also modify glutamine dehydrogenase. J Biol Chem 263:13, 610-13, 614, 1988.
Miyake R, Gross RW: Multiple phospholipase A2 activities in canine vascular smooth muscle. Biochim Biophys Acta 1165:167–176, 1992.
Davfetov B, Marie-Sontag J-M, Hata Y, Petrenko AG, Fykse EM, Jahn R, Sudhof TC: Phosphorylation of synaptotagmin I by casein kinase II. J Biol Chem 268:6816–6822, 1993.
Cordella-Miele E, Miele L, Beninati S, Mukherjee AB: Transglutaminase-catalyzed incorporation of polyamines into phospholipase A2. J Biochem (Tokyo) 113:164–173, 19
Facchiano F, Benfenati F, Valtorta F, Luini A: Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase. J Biol Chem 268:4588–4591, 1993.
Zünkler B J, Lenzen S, Panten U: D-glucose enhances GTP content in mouse pancreatic islets. IRCS Med Sci 14:354, 355, 1986.
Robertson RP, Seaquist ER, Walseth TF: G proteins and modulation of insulin secretion. Diabetes 40:1–6, 1991.
Helper JR, Gilman AG: G-proteins. TIBS 17:383–387, 1992.
Katada T, Ui M: Islet activating protein. Enhanced secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. J Biol Chem 254:469–479, 1979.
Nakakki G, Nakadate T, Ishili K, Kato R: Postsynaptic alpha 2 adrenergic receptors in isolated rat islets of Langerhans: Inhibition of insulin release and cyclic 3′ 5′ adenosine monophosphate accumulation. J Pharmacol Exp Ther 216:607–614, 1981.
Hillaire-Buys D, Gross R, Roye M, Ribes G, Loubatieres-Mariani M-M: Adrenergic inhibition of insulin secretion involves pertussis toxin-sensitive and-insensitive mechanisms. Eur J Pharmacol 218:3359–3362, 1992.
Morgan NG, Berrows NS: Immunological characterization of pertussis toxin-sensitive G-proteins in isolated islets and cultured insulinoma cells. Diabetologia 35(supp 1):A118, 1992.
Kowluru A, Rabaglia ME, Muse KE, Metz SA: Subcellular localization and kinetic characterization of guanine nucleotide binding proteins in normal rat and human pancreatic islets and transformed beta cells. Biochim Biophys Acta 1994, in press.
Takai Y, Kaibuchi K, Kikuchi A, Kawata M: Small GTP-binding proteins. Int Rev Cytol 133:187–230, 1992.
Kowluru A, Metz SA: Stimulation by prostaglandin E2 of a high affinity GTPase in the secretory granules of normal rat and human pancreatic islets. Biochem J 297:399–406, 1994.
Kowluru A, Metz SA: Regulation of guanine-nucleotide binding proteins in islet subcellular fractions by phospholipase-derived lipid mediators of insulin secretion. Biochim Biophys Acta 1994, in press.
Regazzi R, Vallar L, Ullrich S, Ravazzola M, Kikuchi A, Takai Y, Wollheim CB: Characterization of small-molecular-mass guanine nucleotide-binding regulatory proteins in insulin-secreting cells and PC 12 cells. Eur J Biochem 208:729–737, 1992
Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125–132, 1990.
Boyer JL, Waldo GL, Harden TK: βy-subunit activation of G-protein-regulated phospholipase C.J Biol Chem 267:25, 451-25, 456, 1992.
Katz A, Wu D, Simon MI: Subunits βγ of heterotrimeric G protein activate β2 isoform of phospholipase. Nature 360:686–689, 1992.
Creutz CE: The annexins and exocytosis. Science 258:924–931, 1992.
Zupan LA, Steffans DL, Erry CA, Landt M, Gross RW: Cloning and expression of a human 14-3-3 protein mediating phospholipolysis. J Biol Chem 267:8707–8710, 1992.
Dunlop ME, Larkins RG: Effect of phosphatidic acid on islet cell phosphoinositidehydrolysis, Ca2+,andadenylatecyclase.Diabetes38:1187–1192,1989.
Metz SA, Rabaglia ME, Stock J, Kowluru A: Modulation of insulin secretion from normal rat islets by inhibitors of the posttranslational modifications of GTP-binding proteins. Biochem J, 295:31–40, 1993.
Kowluru A, Rabaglia ME, Stock J, Metz SA: A requirement in exocytotic insulin secretion for GTP-dependent carboxyl methylation of specific islet proteins. Diabetes 42:76A, 1993.
Metz SA: Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. Diabetes 35:808–817, 1986.
Metz SA: Exogenous arachidonic acid promotes insulin release from intact or permeabilized rat islets by dual mechanisms. Diabetes 37:1453–1469, 1988.
Metz SA, Draznin B, Sussman KE, Leitner JW: Unmasking of arachidonate-induced insulin release by removal of extracellular calcium. Biochem Biophys Res Commun 142:251–258, 1987.
Seaquist ER, Walseth TF, Nelson DM, Robertson RP: Pertussis toxin-sensitive G-protein mediation of PGE2 inhibition of cAMP metabolism and phasic glucose-induced insulin secretion in HIT cells. Diabetes 38:1439–1445, 1989.
Sharp GWG, Merchand-Brustel YL, Yada T, Russo LL, Bliss CR, Cormont M, Monge L, Van Obberghen E: Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J Biol Chem 264:7302–7309, 1989.
Persaud SJ, Jones PM, Howell SL: Effects of Bordetella pertussis toxin on catecholamine inhibition of insulin release from intact and electrically permeabilized rat islets. Biochem J 258:669–675, 1989.
Basudev H, Jones PM, Persaud SJ, Howell SL: Arachidonic acid-induced insulin secretion from rat islets of Langerhans is not mediated by protein phosphorylation. Mol Cell Endocrinol 91:193–199, 1993.
Vara E, Tamarit-Rodriguez J: Glucose stimulation of insulin secretion in islets of fed and starved rats and its dependence of lipid metabolism. Metabolism 35:266–271, 1986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kowluru, A., Metz, S.A. (1994). GTP and Its Binding Proteins in the Regulation of Insulin Exocytosis. In: Draznin, B., LeRoith, D. (eds) Molecular Biology of Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0241-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0241-7_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6677-8
Online ISBN: 978-1-4612-0241-7
eBook Packages: Springer Book Archive